Motif Neurotech: $18.75 Million Raised To Develop Minimally-Invasive Bioelectronics For Mental Health
By Annie Baker ● Jan 24, 2024
Motif Neurotech - a neurotechnology company developing minimally-invasive bioelectronics for mental health – recently announced an oversubscribed Series A financing of $18.75 million led by Arboretum Ventures, with participation from new investors KdT Ventures, Satori Neuro, Dolby Family Ventures, re.Mind Capital, individual investor Max Hodak and existing investors Divergent Capital, TMC Innovation, PsyMed Ventures, Empath Ventures and Capital Factory.